New Draft Merger Guidelines Signal Increased Scrutiny for M&A Deals

The US federal antitrust enforcement bodies have released a long-awaited draft of merger guidelines, according to JD Supra. These new draft guidelines are geared towards shaping the review process of mergers and acquisitions and embody significant changes to the existing enforcement policy. This update holds substantial implications for future Mergers & Acquisitions (M&A) plans of…

Read More

Rise in EBITDA-Based Metrics Revolutionizes Earnout Payments in Mergers and Acquisitions

There has been a remarkable change in the metrics used to calculate earnout payments in recent years. According to analysis of the Goodwin Private Equity Deals Database, there’s a shift towards the use of EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) as a crucial determinant. The analysis indicates that EBITDA became almost as prevalent…

Read More

EU Foreign Subsidies Regulation in Effect: Strengthening Competition Law and Shaping the Global Economic Landscape

As of now, the EU Foreign Subsidies Regulation (FSR) – which oversees cross-border monetary contributions – has officially taken effect. The European Commission (EC) will gain increased regulatory power thanks to the FSR. This outcome comes as part of a commitment to reduce distortion to competition within the EU’s internal market, a disruption which traditionally…

Read More

DOJ and FTC Draft Guidelines Signal Shift in US Merger Enforcement Policies

The U.S. Department of Justice (DOJ) and Federal Trade Commission (FTC) have issued draft guidelines concerning the application of U.S. antitrust laws to merger investigations. This represents a significant shift in policy direction, calling into question decades of legal precedent on merger enforcement. Significantly, the draft guidelines propose an abandonment of competitive effects analyses, which…

Read More

WM Partners Acquires Allergy Research Group, Signaling Enhanced Investment in Healthcare Sector

In a recent development in the healthcare and life sciences private equity space, WM Partners has completed the acquisition of Allergy Research Group from Kikkoman Corp. This transaction marks a significant venture for WM Partners into the thriving sector of healthcare. As reported by JD Supra, the details of the transaction have not been fully…

Read More

Distressed M&A Surge Looms: Preparing for Complex Transactions in Retail Sector

As the globe continues to navigate an uncertain economic landscape, with challenges such as climbing interest rates, inflation and the looming threat of a potential recession, the Mergers and Acquisitions (M&A) activity landscape is also adjusting. Industry experts suggest that the future may include an increased prevalence of transactions involving distressed targets, particularly within the…

Read More